Steminent Biotherapeutics Inc. (TPEX:7729)
Taiwan · Delayed Price · Currency is TWD 88.10
-1.90 (-2.11%)
Jan 22, 2026, 1:08 PM CST
Steminent Biotherapeutics Market Cap
Steminent Biotherapeutics has a market cap or net worth of 6 billion as of January 21, 2026. Its market cap has increased by 385.98% in one year.
Market Cap
6.00B
Enterprise Value
5.91B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
88.10
Market Cap Chart
Since March 11, 2024, Steminent Biotherapeutics's market cap has increased from 2.24B to 6.00B, an increase of 167.71%. That is a compound annual growth rate of 69.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 5.81B | 45.09% |
| Dec 31, 2025 | 4.00B | 211.83% |
| Dec 31, 2024 | 1.28B | -42.67% |
| Mar 11, 2024 | 2.24B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OBI Pharma | 6.99B |
| Savior Lifetec | 6.41B |
| Pharmosa Biopharm | 6.27B |
| CHO Pharma | 6.14B |
| Sinphar Pharmaceutical | 5.86B |
| Locus Cell | 5.80B |
| Panion & Bf Biotech | 5.53B |
| UnicoCell Biomed | 5.24B |